Peptide Therapy Insights
Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.
Why Amazon Removed Bacteriostatic Water — And Where to Buy It Now (2026)
Amazon quietly delisted bacteriostatic water across 2024–2026 — no press release, no customer notice, listings simply vanished. Behind the removal: a prescription-only label Amazon's policy couldn't accommodate, FDA warning letters turning BAC water into legal evidence of intended human injection use, independent testing that found 9 of 11 Amazon products failed basic quality standards, and a growing wave of sterile water lawsuits that made the liability math untenable. Here is a complete breakdown of what happened and where to get pharmaceutical-grade BAC water now.
More in News
FDA Panel Votes 8–6 to Clear BPC-157, TB-500 & 4 Peptides for Compounding (July 2026)
The FDA's Pharmacy Compounding Advisory Committee voted 8–6 to recommend six popular peptides — including BPC-157 and TB-500 — for the 503A Bulk Drug Substances list. The vote is historic but non-binding: formal FDA rulemaking, which typically takes 8–12 months, must follow before compounding pharmacies have legal authority to prepare them. Here is a complete breakdown of the vote, what it means for access, and what happens next.
Peptide Sciences Shuts Down: What Happened and What It Means
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
US Injectable Peptides Craze: What Patients Need to Know
The injectable peptides craze is sweeping the US, with many individuals experimenting for various health benefits. Learn the key facts and implications for patients.
NewsUnproven Peptides Gain Popularity: Risks and Concerns
The influence of social media is driving the popularity of unproven peptides, raising concerns among medical professionals. Discover the risks and what this means for patients.
NewsFDA Implements New Restrictions on Mass-Marketed Compounded GLP-1 Products
NewsInjectable Peptide Therapy Gains Mainstream Acceptance in 2025
NewsGLP-1 Market Growth Projected to Hit $33.26 Billion by 2030: Implications for Obesity and Diabetes Therapies
NewsNovartis and Unnatural Collaborate on Innovative Macrocyclic Peptide Therapies
Stay Up to Date
New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.